WATCH THE VIDEO HERE Naijaonpoint reports that Zicsaloma, in a post via his Instagram page on Friday, April 18, 2025, labelled the medical system in Nigeria as terrible, claiming that his mother was denied entry into LUTH by hospital security personnel and a doctor, despite her critical condition. Recounting the incident at the hospital, Zicsaloma said that upon arriving at LUTH, his mother was turned away and directed to a test centre for further diagnostics. He further claimed that, despite undergoing the required tests, his mother was still denied entry. The skitmaker called on the government to urgently investigate the operations at LUTH, describing the experience as a glaring example of the need for systemic reforms in Nigeria’s healthcare sector. He said, “Our medical system is terrible. My mom, who is undergoing chemotherapy and is at the point of death, was refused entry into LUTH. We rushed her from the Island to the hospital on Okin Road, where we were told to return to LUTH because that’s where she had her initial chemotherapy. They warned us she might not make it if we didn’t act fast. “They locked my mom, my sister, and a friend I sent to assist them outside the gate. The security guard said they couldn’t let her in until her test results were out, which would take three hours. They claimed only a doctor could grant access, but when a doctor eventually arrived, he refused to speak to me over the phone and told my sister he wouldn’t examine my mom until the results were ready. “We begged the doctor to at least look at her, but he walked away. My mom is a skeletal version of herself. Someone who’s already lifeless was just left outside like that. Where is the humanity? “The government needs to look into that hospital. This is not just about my mother—it’s about the lives of many Nigerians who may not have a voice.”
Nigerian skitmaker, Aloma Isaac, better known as Zicsaloma, has called out the Lagos University Teaching Hospital (LUTH) for alleged unprofessional and inhumane treatment of his mother battling cancer.